SP1 and Miyoshi myopathy: Our recent studies also showed that MIAT levels are negatively correlated with miR-29b in patients with MM, and MIAT inhibited miR-29b expression through a direct interaction, leading to increased expression of the miR-29b target genes Mcl-1, CDK-6, PSME4, and SP-1.